Pliant Therapeutics, Inc. Share Price
NASDAQ: PLRX | Micro CapPliant Therapeutics, Inc. Stock Performance
Open $1.04 | Prev. Close $1.05 | Circuit Range N/A |
Day Range $1.03 - $1.07 | Year Range $1.03 - $1.94 | Volume 22,652 |
Average Traded $1.05 |
Pliant Therapeutics, Inc. Share Price Today
As of 10 August 2026, Pliant Therapeutics, Inc.'s share price is $1.06. The stock opened at $1.04, compared to its previous close of $1.05. During today's trading session, Pliant Therapeutics, Inc.'s share price traded between $1.03 and $1.07, with an average price of $1.05. Over the past 52 weeks, the stock has recorded a high of $1.94 and a low of $1.03. In terms of performance, Pliant Therapeutics, Inc.'s share price has declined by 17.44% over the last six months and is down 35.06% on a year-on-year basis.
Pliant Therapeutics, Inc. Share Price Chart
Pliant Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $65.36M | PE Ratio (TTM) -0.44 | Dividend Yield N/A |
EPS (TTM) $-2.43 | Revenue (TTM) N/A | Return On Equity (TTM) -82.42% |
Profit Margin N/A | Debt to Equity 0.09 | Quarterly Earnings Growth YoY N/A |
Pliant Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Pliant Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Pliant Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.05 | $1.06 | +1.44% |
Jul 2026 | $1.15 | $1.04 | -8.33% |
Jun 2026 | $1.25 | $1.14 | -10.24% |
May 2026 | $1.22 | $1.27 | +3.67% |
Apr 2026 | $1.29 | $1.23 | -3.92% |
Mar 2026 | $1.26 | $1.27 | -1.16% |
Feb 2026 | $1.22 | $1.29 | +5.74% |
Jan 2026 | $1.23 | $1.22 | +0.83% |
Dec 2025 | $1.58 | $1.21 | -24.84% |
Nov 2025 | $1.72 | $1.61 | -4.45% |
Oct 2025 | $1.48 | $1.69 | +14.24% |
Sep 2025 | $1.61 | $1.48 | -10.06% |
PLRX Share Price FAQs
What is Pliant Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Pliant Therapeutics, Inc. stock?
What is PLRX's market capitalisation today?
What is PLRX's net income for the last quarter?
What is the 5 year returns of PLRX?
What is the high & low stock price of PLRX today?
Can I buy PLRX shares in India?